Olon USA LLC

Painesville, OH

UEI
JV89LJEJJ516
CAGE
7YLD6
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
7528 Auburn Rd, Painesville, OH 44077, USA
Website
olonricerca.com
Founded
1986
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Drug manufacturing supporting malaria research W81XWH18C0021 Medical Command (Army) $185,566

Grant subawards

Prime recipient Prime award Amount Awarded
Emory University Antiviral Countermeasures Development Center (AC/DC) U19AI171403 $130,500
Emory University Antiviral Countermeasures Development Center (AC/DC) U19AI171403 $41,800
Emory University Antiviral Countermeasures Development Center (AC/DC) U19AI171403 $307,000
Emory University Antiviral Countermeasures Development Center (AC/DC) U19AI171403 $174,000

Similar vendors

About the company

Olon USA LLC, a for-profit manufacturer of goods based in Painesville, Ohio, operates predominantly as a sub-recipient on federal biomedical research grants, with minimal recent prime activity. The vendor has completed five federal awards since 2017, of which four are grant sub-awards (80% of the footprint) and one is a prime award to the Department of the Army Medical Command. Combined potential value across all awards stands at $186 thousand, though obligated dollars total $839 thousand — indicating that work performed has exceeded initial potential-value estimates by a significant margin. The vendor carries no current or past SBA designations in the source data.

Olon's customer base is concentrated in biomedical research. The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases accounts for four awards, all routed through Emory University as the prime grant recipient under the Antiviral Countermeasures Development Center (AC/DC) program. Olon serves as a sub-recipient on all four of these grants, with award dates spanning August 2024, January 2026, May 22, 2026, and May 29, 2026. The single prime award went to the Department of the Army Medical Command for $186 thousand in potential value. The vendor's NAICS footprint sits primarily in All Other Professional, Scientific, and Technical Services, with PSC coding tied to health research and development services.

Activity has been episodic: one award in 2017, a gap through 2023, then resumption in 2024 with three awards in 2026. One award (combined potential value $186 thousand) faces completion within the next twenty-four months, exposing the vendor to recompete or renewal decision in that window. Olon's capability profile, as evidenced by grant sub-award work, centers on antiviral countermeasures development and biomedical research support services delivered to NIH-funded research centers.

Quick answers

Is Olon USA LLC registered in SAM.gov?

Yes. Olon USA LLC's SAM.gov registration is active through January 19, 2027.

What is Olon USA LLC's most recent federal award?

Olon USA LLC's most recent federal contract award is Drug manufacturing supporting malaria research (W81XWH18C0021), from Medical Command (Army), on October 18, 2017.

On GovTribe

See Olon USA LLC's full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors